Novo Nordisk rode Ozempic's success to becoming Europe's top company. Now it's faltering and its CEO is out. Novo Nordisk rode Ozempic's success to becoming Europe's top company. Now it's faltering ...

Lars Fruergaard Jørgensen, the chief executive of once-highflying Danish drug manufacturer Novo Nordisk, is stepping down after eight years in the role, the maker of the drugs Ozempic and Wegovy ...

China's ATXG (NASDAQ: ATXG) plans to acquire up to $800M in crypto through a share-based deal, signaling a pivot into the ...

The US Securities and Exchange Commission is probing whether Coinbase misled investors by reporting inflated user numbers ...

Coinbase CEO Brian Armstrong is on the hunt for more mergers and acquisitions after scooping up crypto derivatives platform ...

The deal highlights the UAE’s rising role in the Middle East’s digital assets industry, with law firms acting as key ...

Coinbase CEO Brian Armstrong says the company is exploring acquisition opportunities after its $2.9 billion Deribit buy.

Coinbase is evolving from a trading-fee-dependent crypto exchange to a durable infrastructure provider. Read why I rate COIN ...

Coinbase's CEO signaled the company will continue exploring mergers, leveraging its strong financial position after the $2.9b ...

Coinbase CEO Brian Armstrong hints at more acquisitions following a $2.9 billion deal to buy crypto derivatives giant Deribit ...

Coinbase CEO Brian Armstrong discusses ongoing acquisitions strategy post-Deribit purchase, focusing on global opportunities ...

Coinbase Global Inc., the largest US cryptocurrency exchange, will be added to the S&P 500 Index in the latest milestone for ...